213 related articles for article (PubMed ID: 33159234)
1. Medulloblastoma: "Onset of the molecular era".
Dhanyamraju PK; Patel TN; Dovat S
Mol Biol Rep; 2020 Dec; 47(12):9931-9937. PubMed ID: 33159234
[TBL] [Abstract][Full Text] [Related]
2. Molecular Classification of Medulloblastoma.
Kijima N; Kanemura Y
Neurol Med Chir (Tokyo); 2016 Nov; 56(11):687-697. PubMed ID: 27238212
[TBL] [Abstract][Full Text] [Related]
3. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
Schwalbe EC; Lindsey JC; Nakjang S; Crosier S; Smith AJ; Hicks D; Rafiee G; Hill RM; Iliasova A; Stone T; Pizer B; Michalski A; Joshi A; Wharton SB; Jacques TS; Bailey S; Williamson D; Clifford SC
Lancet Oncol; 2017 Jul; 18(7):958-971. PubMed ID: 28545823
[TBL] [Abstract][Full Text] [Related]
4. G-protein coupled receptor expression patterns delineate medulloblastoma subgroups.
Whittier KL; Boese EA; Gibson-Corley KN; Kirby PA; Darbro BW; Qian Q; Ingram WJ; Robertson T; Remke M; Taylor MD; O'Dorisio MS
Acta Neuropathol Commun; 2013 Oct; 1():66. PubMed ID: 24252460
[TBL] [Abstract][Full Text] [Related]
5. Picosecond Infrared Laser Desorption Mass Spectrometry Identifies Medulloblastoma Subgroups on Intrasurgical Timescales.
Woolman M; Kuzan-Fischer CM; Ferry I; Kiyota T; Luu B; Wu M; Munoz DG; Das S; Aman A; Taylor MD; Rutka JT; Ginsberg HJ; Zarrine-Afsar A
Cancer Res; 2019 May; 79(9):2426-2434. PubMed ID: 30890619
[TBL] [Abstract][Full Text] [Related]
6. Medulloblastoma: Molecular Classification-Based Personal Therapeutics.
Archer TC; Mahoney EL; Pomeroy SL
Neurotherapeutics; 2017 Apr; 14(2):265-273. PubMed ID: 28386677
[TBL] [Abstract][Full Text] [Related]
7. Signaling pathway and molecular subgroups of medulloblastoma.
Li KK; Lau KM; Ng HK
Int J Clin Exp Pathol; 2013; 6(7):1211-22. PubMed ID: 23826403
[TBL] [Abstract][Full Text] [Related]
8. Medulloblastoma: From Molecular Subgroups to Molecular Targeted Therapies.
Wang J; Garancher A; Ramaswamy V; Wechsler-Reya RJ
Annu Rev Neurosci; 2018 Jul; 41():207-232. PubMed ID: 29641939
[TBL] [Abstract][Full Text] [Related]
9. Medulloblastoma: Molecular understanding, treatment evolution, and new developments.
Liu X; Ding C; Tan W; Zhang A
Pharmacol Ther; 2020 Jun; 210():107516. PubMed ID: 32105673
[TBL] [Abstract][Full Text] [Related]
10. Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy.
Blüml S; Margol AS; Sposto R; Kennedy RJ; Robison NJ; Vali M; Hung LT; Muthugounder S; Finlay JL; Erdreich-Epstein A; Gilles FH; Judkins AR; Krieger MD; Dhall G; Nelson MD; Asgharzadeh S
Neuro Oncol; 2016 Jan; 18(1):126-31. PubMed ID: 26254476
[TBL] [Abstract][Full Text] [Related]
11. Pathology, diagnostics, and classification of medulloblastoma.
Orr BA
Brain Pathol; 2020 May; 30(3):664-678. PubMed ID: 32239782
[TBL] [Abstract][Full Text] [Related]
12. Molecular subgroups of medulloblastoma: the current consensus.
Taylor MD; Northcott PA; Korshunov A; Remke M; Cho YJ; Clifford SC; Eberhart CG; Parsons DW; Rutkowski S; Gajjar A; Ellison DW; Lichter P; Gilbertson RJ; Pomeroy SL; Kool M; Pfister SM
Acta Neuropathol; 2012 Apr; 123(4):465-72. PubMed ID: 22134537
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pre-clinical utility of genomics in medulloblastoma.
Nör C; Ramaswamy V
Expert Rev Neurother; 2018 Aug; 18(8):633-647. PubMed ID: 30032687
[TBL] [Abstract][Full Text] [Related]
14. Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical Practice.
Gupta T; Shirsat N; Jalali R
Curr Pediatr Rev; 2015; 11(2):106-19. PubMed ID: 26133181
[TBL] [Abstract][Full Text] [Related]
15. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
[TBL] [Abstract][Full Text] [Related]
16. Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy.
Cacciotti C; Fleming A; Ramaswamy V
J Pathol; 2020 Jul; 251(3):249-261. PubMed ID: 32391583
[TBL] [Abstract][Full Text] [Related]
17. Subgroup-specific alternative splicing in medulloblastoma.
Dubuc AM; Morrissy AS; Kloosterhof NK; Northcott PA; Yu EP; Shih D; Peacock J; Grajkowska W; van Meter T; Eberhart CG; Pfister S; Marra MA; Weiss WA; Scherer SW; Rutka JT; French PJ; Taylor MD
Acta Neuropathol; 2012 Apr; 123(4):485-499. PubMed ID: 22358458
[TBL] [Abstract][Full Text] [Related]
18. Pediatric medulloblastoma in the molecular era: what are the surgical implications?
Kameda-Smith MM
Cancer Metastasis Rev; 2020 Mar; 39(1):235-243. PubMed ID: 32095940
[TBL] [Abstract][Full Text] [Related]
19. Nomograms based on preoperative multiparametric magnetic resonance imaging for prediction of molecular subgrouping in medulloblastoma: results from a radiogenomics study of 111 patients.
Dasgupta A; Gupta T; Pungavkar S; Shirsat N; Epari S; Chinnaswamy G; Mahajan A; Janu A; Moiyadi A; Kannan S; Krishnatry R; Sastri GJ; Jalali R
Neuro Oncol; 2019 Jan; 21(1):115-124. PubMed ID: 29846693
[TBL] [Abstract][Full Text] [Related]
20. Molecular Classification of Medullobastomas by Whole Genome Expression Profiling.
Nosková H; Adamcová S; Knoflíčková LDR; Pavelka Z; Vejmělková K; Zitterbart K; Slabý O; Štěrba J
Klin Onkol; 2019; 32(Supplementum1):171-173. PubMed ID: 31064192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]